Journal article · 2022
Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale
British Journal of Dermatology, 186(1), 96–105 · Published 1 January 2022 · DOI 10.1111/bjd.20688
In brief
“Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale” is a 2022 journal article by Jordan Sibéoni and 8 co-authors, published in British Journal of Dermatology. OpenAlex counts 8 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 8
- Most cited in
- 2022 (3)
- Field-weighted impact
- 0.96
- References
- 53
- Authors
- 9
Abstract
BACKGROUND: Hand involvement in systemic sclerosis (SSc) is at the core of the disease, with a substantial impact on both functional aspects and quality of life. There is no patient-reported outcome (PRO) scale globally assessing hand involvement in SSc. OBJECTIVES: To develop and validate a PRO scale, the Hand scleroDerma lived Experience (HAnDE) scale, to… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sibéoni, J., Dunogué, B., Dupont, A., Haiddar, D., Benmostefa, N., Falissard, B., Mouthon, L., Révah‐Levy, A., & Verneuil, L. (2022). Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale. British Journal of Dermatology, 186(1), 96–105. https://doi.org/10.1111/bjd.20688
MLA 9
Sibéoni, Jordan, et al. “Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale.” British Journal of Dermatology, vol. 186, no. 1, 2022, pp. 96–105. https://doi.org/10.1111/bjd.20688.
Chicago
Sibéoni, Jordan, Bertrand Dunogué, A. Dupont, D. Haiddar, Nouria Benmostefa, Bruno Falissard, Luc Mouthon, Anne Révah‐Levy, and L. Verneuil. 2022. “Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale.” British Journal of Dermatology 186 (1): 96–105. https://doi.org/10.1111/bjd.20688.
Harvard
Sibéoni, J. et al. (2022) ‘Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale’, British Journal of Dermatology, 186(1), pp. 96–105. doi:10.1111/bjd.20688.
IEEE
J. Sibéoni et al., “Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale,” British Journal of Dermatology, vol. 186, no. 1, pp. 96–105, 2022, doi: 10.1111/bjd.20688.
BibTeX
@article{sibeoni2022development,
title = {{Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale}},
author = {Sibéoni, Jordan and Dunogué, Bertrand and Dupont, A. and Haiddar, D. and Benmostefa, Nouria and Falissard, Bruno and Mouthon, Luc and Révah‐Levy, Anne and Verneuil, L.},
journal = {British Journal of Dermatology},
year = {2022},
volume = {186},
number = {1},
pages = {96--105},
doi = {10.1111/bjd.20688},
url = {https://doi.org/10.1111/bjd.20688}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 3 | |
| 2023 | 1 | |
| 2024 | 1 | |
| 2025 | 2 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.96: it has been cited 0.96 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- hand involvement
- patient-reported outcomes
- lived experience
- psychometric validation
- hand function
- quality of life
- psychosocial impact
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Sibéoni, J., Dunogué, B., Dupont, A., Haiddar, D., Benmostefa, N., Falissard, B., Mouthon, L., Révah‐Levy, A., & Verneuil, L. (2022). Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale. British Journal of Dermatology, 186(1), 96–105. https://doi.org/10.1111/bjd.20688
How many times has this paper been cited?
8 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Jordan Sibéoni, Bertrand Dunogué, A. Dupont, D. Haiddar, Nouria Benmostefa, Bruno Falissard, Luc Mouthon, Anne Révah‐Levy, L. Verneuil.
What is the DOI of this paper?
10.1111/bjd.20688, permanently at https://doi.org/10.1111/bjd.20688. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.